Dexmedetomidine versus propofol sedation in flexible bronchoscopy: a randomized controlled trial

Barak Pertzov, Boris Krasulya, Karam Azem, Yael Shostak, Shimon Izhakian, Dror Rosengarten, Svetlana Kharchenko, Mordechai R Kramer, Barak Pertzov, Boris Krasulya, Karam Azem, Yael Shostak, Shimon Izhakian, Dror Rosengarten, Svetlana Kharchenko, Mordechai R Kramer

Abstract

Background: Dexmedetomidine (DEX), is a highly selective alpha2 adrenoceptor (α2-AR) agonist, successfully used in various procedures including flexible bronchoscopy. Randomized controlled trials (RCTs) evaluating DEX sedation during bronchoscopy report equivocal results regarding respiratory and hemodynamic outcomes.

Methods: We conducted an RCT to evaluate the efficacy and safety of dexmedetomidine compared to propofol for sedation during bronchoscopy. The primary outcome was the number of desaturation events, secondary outcomes were transcutaneous Pco2 level, hemodynamic adverse events and physician and patient satisfaction.

Results: Overall, 63 patients were included, 30 and 33 in the DEX and propofol groups, respectively. The number of desaturation events was similar between groups, median (IQR) 1 (0-1) and 1 (0-2) in the DEX and control groups, respectively (P = 0.29). Median desaturation time was 1 (0-2) and 1 (0-3) minutes in the DEX and control groups, respectively (P = 0.48). Adverse events included hypotension, 33% vs 21.1% in intervention and control groups, respectively (P = 0.04), bradycardia, cough, and delayed recovery from sedation. Total adverse events were 22 and 7 in DEX and propofol groups, respectively (P = 0.009).

Conclusion: Dexmedetomidine sedation during bronchoscopy did not show differences in oxygen saturation and transcutaneous CO2 level in comparison to propofol. Moreover, DEX sedation required a significantly higher number of rescue boluses, due to inadequate sedation and was associated with a higher rate of adverse events. Trial registration NCT04211298, registration date: 26.12.2019.

Keywords: Adverse events; Desaturation; Dexmedetomidine; Flexible bronchoscopy; Sedation.

Conflict of interest statement

The authors have no competing interests to declare.

© 2022. The Author(s).

References

    1. Du Rand IA, Blaikley J, Booton R, Chaudhuri N, Gupta V, Khalid S, et al. Summary of the British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults. Thorax. 2013;68(8):786–787. doi: 10.1136/thoraxjnl-2013-203629.
    1. American Thoracic Society. Medical Section of the American Lung Association Position paper on guidelines for fiberoptic bronchoscopy in adults. Am Rev Respir Dis. 1987;136(4):1066. doi: 10.1164/ajrccm/136.4.1066.
    1. Sarkiss M. Anesthesia for bronchoscopy and interventional pulmonology: from moderate sedation to jet ventilation. Curr Opin Pulm Med. 2011;17(4):274–278. doi: 10.1097/MCP.0b013e3283471227.
    1. Goudra BG, Singh PM, Borle A, Farid N, Harris K. Anesthesia for advanced bronchoscopic procedures: state-of-the-art review. Lung. 2015;193(4):453–465. doi: 10.1007/s00408-015-9733-7.
    1. Barends CRM, Absalom A, van Minnen B, Vissink A, Visser A. Dexmedetomidine versus Midazolam in procedural sedation. A systematic review of efficacy and safety. PLoS ONE. 2017;12(1):e0169525. doi: 10.1371/journal.pone.0169525.
    1. Naaz S, Ozair E. Dexmedetomidine in current anaesthesia practice—a review. J Clin Diagn Res JCDR. 2014;8(10):GE01–04.
    1. Goyal R, Hasnain S, Mittal S, Shreevastava S. A randomized, controlled trial to compare the efficacy and safety profile of a dexmedetomidine-ketamine combination with a propofol-fentanyl combination for ERCP. Gastrointest Endosc. 2016;83(5):928–933. doi: 10.1016/j.gie.2015.08.077.
    1. Eberl S, Preckel B, Bergman JJ, van Dieren S, Hollmann MW. Satisfaction and safety using dexmedetomidine or propofol sedation during endoscopic oesophageal procedures: a randomised controlled trial. Eur J Anaesthesiol. 2016;33(9):631–637. doi: 10.1097/EJA.0000000000000438.
    1. Zhang X-K, Chen Q-H, Wang W-X, Hu Q. Evaluation of dexmedetomidine in combination with sufentanil or butorphanol for postoperative analgesia in patients undergoing laparoscopic resection of gastrointestinal tumors: a quasi-experimental trial. Medicine (Baltimore) 2016;95(50):e5604. doi: 10.1097/MD.0000000000005604.
    1. Lu Z, Li W, Chen H, Qian Y. Efficacy of a Dexmedetomidine-Remifentanil combination compared with a Midazolam-Remifentanil combination for conscious sedation during therapeutic endoscopic retrograde cholangio-pancreatography: a prospective, randomized, single-blinded preliminary trial. Dig Dis Sci. 2018;63(6):1633–1640. doi: 10.1007/s10620-018-5034-3.
    1. Kinugasa H, Higashi R, Miyahara K, Moritou Y, Hirao K, Ogawa T, et al. Dexmedetomidine for conscious sedation with colorectal endoscopic submucosal dissection: a prospective double-blind randomized controlled study. Clin Transl Gastroenterol. 2018;9(7):167. doi: 10.1038/s41424-018-0032-5.
    1. Ghali A, Mahfouz AK, Ihanamäki T, El Btarny AM. Dexmedetomidine versus propofol for sedation in patients undergoing vitreoretinal surgery under sub-Tenon’s anesthesia. Saudi J Anaesth. 2011;5(1):36–41. doi: 10.4103/1658-354X.76506.
    1. Jalowiecki P, Rudner R, Gonciarz M, Kawecki P, Petelenz M, Dziurdzik P. Sole use of dexmedetomidine has limited utility for conscious sedation during outpatient colonoscopy. Anesthesiology. 2005;103(2):269–273. doi: 10.1097/00000542-200508000-00009.
    1. Cooper L, Candiotti K, Gallagher C, Grenier E, Arheart KL, Barron ME. A randomized, controlled trial on dexmedetomidine for providing adequate sedation and hemodynamic control for awake, diagnostic transesophageal echocardiography. J Cardiothorac Vasc Anesth. 2011;25(2):233–237. doi: 10.1053/j.jvca.2010.06.006.
    1. Kaygusuz K, Gokce G, Gursoy S, Ayan S, Mimaroglu C, Gultekin Y. A comparison of sedation with dexmedetomidine or propofol during shockwave lithotripsy: a randomized controlled trial. Anesth Analg. 2008;106(1):114–119. doi: 10.1213/01.ane.0000296453.75494.64.
    1. Ryu JH, Lee SW, Lee JH, Lee EH, Do SH, Kim CS. Randomized double-blind study of remifentanil and dexmedetomidine for flexible bronchoscopy. Br J Anaesth. 2012;108(3):503–511. doi: 10.1093/bja/aer400.
    1. Zhang Q, Zhou J, He Q, Guan S, Qiu H, Xu X, et al. Dexmedetomidine combined with midazolam infusion guided by bispectral index during bronchoscopy. Clin Respir J. 2021 doi: 10.1111/crj.13383.
    1. Yuan F, Fu H, Yang P, Sun K, Wu S, Lv M, et al. Dexmedetomidine-fentanyl versus propofol-fentanyl in flexible bronchoscopy: a randomized study. Exp Ther Med. 2016;12(1):506–512. doi: 10.3892/etm.2016.3274.
    1. Lin T-Y, Huang Y-C, Kuo C-H, Chung F-T, Lin Y-T, Wang T-Y, et al. Dexmedetomidine sedation for endobronchial ultrasound-guided transbronchial needle aspiration, a randomised controlled trial. ERJ Open Res. 2020 doi: 10.1183/23120541.00064-2020.
    1. St-Pierre P, Tanoubi I, Verdonck O, Fortier L-P, Richebé P, Côté I, et al. Dexmedetomidine versus Remifentanil for monitored anesthesia care during endobronchial ultrasound-guided transbronchial needle aspiration: a randomized controlled trial. Anesth Analg. 2019;128(1):98–106. doi: 10.1213/ANE.0000000000003633.
    1. Kumari R, Jain K, Agarwal R, Dhooria S, Sehgal IS, Aggarwal AN. Fixed dexmedetomidine infusion versus fixed-dose midazolam bolus as primary sedative for maintaining intra-procedural sedation during endobronchial ultrasound-guided transbronchial needle aspiration: a double blind randomized controlled trial. Expert Rev Respir Med. 2021;15:1597–1604. doi: 10.1080/17476348.2021.1918000.
    1. Kim J, Choi SM, Park YS, Lee C-H, Lee S-M, Yoo C-G, et al. Dexmedetomidine versus midazolam for sedation during endobronchial ultrasound-guided transbronchial needle aspiration: a randomised controlled trial. Eur J Anaesthesiol. 2021;38(5):534–540. doi: 10.1097/EJA.0000000000001370.
    1. Magazine R, Venkatachala SK, Goneppanavar U, Surendra VU, Guddattu V, Chogtu B. Comparison of midazolam and low-dose dexmedetomidine in flexible bronchoscopy: a prospective, randomized, double-blinded study. Indian J Pharmacol. 2020;52(1):23–30. doi: 10.4103/ijp.IJP_287_19.
    1. Li H, Zhang N, Zhang K, Wei Y. Observation of the clinical efficacy of dexmedetomidine in flexible bronchoscopy under general anesthesia: clinical case experience exchange. J Int Med Res. 2019;47(12):6215–6222. doi: 10.1177/0300060519880763.
    1. Riachy M, Khayat G, Ibrahim I, Aoun Z, Dabar G, Bazarbachi T, et al. A randomized double-blind controlled trial comparing three sedation regimens during flexible bronchoscopy: dexmedetomidine, alfentanil and lidocaine. Clin Respir J. 2018;12(4):1407–1415. doi: 10.1111/crj.12669.
    1. Goneppanavar U, Magazine R, Periyadka Janardhana B, Krishna Achar S. Intravenous dexmedetomidine provides superior patient comfort and tolerance compared to intravenous Midazolam in patients undergoing flexible bronchoscopy. Pulm Med. 2015;2015:727530. doi: 10.1155/2015/727530.
    1. Liao W, Ma G, Su QG, Fang Y, Gu BC, Zou XM. Dexmedetomidine versus midazolam for conscious sedation in postoperative patients undergoing flexible bronchoscopy: a randomized study. J Int Med Res. 2012;40(4):1371–1380. doi: 10.1177/147323001204000415.
    1. Korkmaz Ekren P, Basarik Aydogan B, Gurgun A, Tasbakan MS, Bacakoglu F, Nava S. Can fiberoptic bronchoscopy be applied to critically ill patients treated with noninvasive ventilation for acute respiratory distress syndrome? Prospective observational study. BMC Pulm Med. 2016;16(1):89. doi: 10.1186/s12890-016-0236-y.
    1. Combe BL, Messika J, Labbé V, Razazi K, Maitre B, Sztrymf B, et al. High-flow nasal oxygen for bronchoalveolar lavage in acute respiratory failure patients. Eur Respir J. 2016;47(4):1283–1286. doi: 10.1183/13993003.01883-2015.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere